Literature DB >> 8879220

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

H Kanzler1, R Küppers, M L Hansmann, K Rajewsky.   

Abstract

In Hodgkin's disease (HD), the Hodgkin and Reed-Sternberg (HRS) cells represent only a minute population in the diseased tissue. The investigation of lineage derivation and clonal origin of these cells has yielded conflicting results. We have analyzed HRS cells micromanipulated from infiltrated tissue sections of 10 primary HD patients for rearranged V genes, extending a previous study. Clonally related rearrangements were found in nine cases, indicating that HRS cells represent a dominant clone of B lineage-derived cells in at least a large fraction of cases of HD. Rearranged VH genes from HRS cells carried a high load of somatic mutation, indicating that HRS cells are derived from germinal center (GC) cells or their progeny. Stop codons in some in-frame V gene rearrangements suggest that the HRS cell precursors reside inside GCs, have acquired crippling mutations that prevent antigenic selection, but escape apoptosis through some transforming event.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879220      PMCID: PMC2192840          DOI: 10.1084/jem.184.4.1495

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

Review 1.  Somatic hypermutation.

Authors:  M S Neuberger; C Milstein
Journal:  Curr Opin Immunol       Date:  1995-04       Impact factor: 7.486

2.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

3.  Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients.

Authors:  G Sitar; E Brusamolino; C Bernasconi; E Ascari
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

4.  Immunoglobulin V genes in Reed-Sternberg cells.

Authors:  A Tbakhi; J Sreenan; R R Tubbs
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

5.  Immunoglobulin V genes in Reed-Sternberg cells.

Authors:  L Trümper; H Daus; A Gause; M Pfreundschuh
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

6.  Immunoglobulin V genes in Reed-Sternberg cells.

Authors:  R Küppers; H Kanzler; M L Hansmann; K Rajewsky
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

7.  Hodgkin cells accumulate mRNA for bcl-2.

Authors:  K Hell; J Lorenzen; R Fischer; M L Hansmann
Journal:  Lab Invest       Date:  1995-10       Impact factor: 5.662

8.  Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells.

Authors:  M Hummel; K Ziemann; H Lammert; S Pileri; E Sabattini; H Stein
Journal:  N Engl J Med       Date:  1995-10-05       Impact factor: 91.245

9.  Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease.

Authors:  K Weber-Matthiesen; J Deerberg; M Poetsch; W Grote; B Schlegelberger
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Content and organization of the human Ig VH locus: definition of three new VH families and linkage to the Ig CH locus.

Authors:  J E Berman; S J Mellis; R Pollock; C L Smith; H Suh; B Heinke; C Kowal; U Surti; L Chess; C R Cantor
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  143 in total

1.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.

Authors:  A van den Berg; L Visser; S Poppema
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Regulation of CD30 antigen expression and its potential significance for human disease.

Authors:  M E Kadin
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.

Authors:  A Staratschek-Jox; S Kotkowski; G Belge; T Rüdiger; J Bullerdiek; V Diehl; J Wolf
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.

Authors:  Ryouichi Horie; Takuro Watanabe; Kinji Ito; Yasuyuki Morisita; Mariko Watanabe; Takaomi Ishida; Masaaki Higashihara; Marshall Kadin; Toshiki Watanabe
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 5.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

6.  Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma.

Authors:  Ewerton M Maggio; Anke Van Den Berg; Debora de Jong; Arjan Diepstra; Sibrand Poppema
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

7.  Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.

Authors:  Olga Bohn; Takahiro Maeda; Alexander Filatov; Andrea Lunardi; Pier Paolo Pandolfi; Julie Teruya-Feldstein
Journal:  Int J Surg Pathol       Date:  2013-12-10       Impact factor: 1.271

8.  In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study.

Authors:  Klaus Willenbrock; Christoph Renné; Philippe Gaulard; Martin-Leo Hansmann
Journal:  Virchows Arch       Date:  2004-10-05       Impact factor: 4.064

Review 9.  Relationship between Hodgkin's and non-Hodgkin's lymphomas.

Authors:  Rose-Marie Amini; Gunilla Enblad
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 10.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.